Your browser doesn't support javascript.
loading
Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots.
Bosilkovska, M; Samer, C F; Déglon, J; Rebsamen, M; Staub, C; Dayer, P; Walder, B; Desmeules, J A; Daali, Y.
Afiliação
  • Bosilkovska M; Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, Switzerland.
  • Samer CF; 1] Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, Switzerland [2] Swiss Center for Applied Human Toxicology, Geneva, Switzerland.
  • Déglon J; Unit of Toxicology, University Center of Legal Medicine, Geneva, Switzerland.
  • Rebsamen M; Department of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.
  • Staub C; Unit of Toxicology, University Center of Legal Medicine, Geneva, Switzerland.
  • Dayer P; 1] Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, Switzerland [2] Swiss Center for Applied Human Toxicology, Geneva, Switzerland.
  • Walder B; Division of Anesthesiology, Geneva University Hospitals, Geneva, Switzerland.
  • Desmeules JA; 1] Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, Switzerland [2] Swiss Center for Applied Human Toxicology, Geneva, Switzerland.
  • Daali Y; 1] Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, Switzerland [2] Swiss Center for Applied Human Toxicology, Geneva, Switzerland.
Clin Pharmacol Ther ; 96(3): 349-59, 2014 Sep.
Article em En | MEDLINE | ID: mdl-24722393
The suitability of the capillary dried blood spot (DBS) sampling method was assessed for simultaneous phenotyping of cytochrome P450 (CYP) enzymes and P-glycoprotein (P-gp) using a cocktail approach. Ten volunteers received an oral cocktail capsule containing low doses of the probes bupropion (CYP2B6), flurbiprofen (CYP2C9), omeprazole (CYP2C19), dextromethorphan (CYP2D6), midazolam (CYP3A), and fexofenadine (P-gp) with coffee/Coke (CYP1A2) on four occasions. They received the cocktail alone (session 1), and with the CYP inhibitors fluvoxamine and voriconazole (session 2) and quinidine (session 3). In session 4, subjects received the cocktail after a 7-day pretreatment with the inducer rifampicin. The concentrations of probes/metabolites were determined in DBS and plasma using a single liquid chromatography-tandem mass spectrometry method. The pharmacokinetic profiles of the drugs were comparable in DBS and plasma. Important modulation of CYP and P-gp activities was observed in the presence of inhibitors and the inducer. Minimally invasive one- and three-point (at 2, 3, and 6 h) DBS-sampling methods were found to reliably reflect CYP and P-gp activities at each session.
Assuntos

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Membro 1 da Subfamília B de Cassetes de Ligação de ATP / Sistema Enzimático do Citocromo P-450 / Teste em Amostras de Sangue Seco Tipo de estudo: Evaluation_studies Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Membro 1 da Subfamília B de Cassetes de Ligação de ATP / Sistema Enzimático do Citocromo P-450 / Teste em Amostras de Sangue Seco Tipo de estudo: Evaluation_studies Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Suíça